Trials & Tribulations Better oncology drug management could lead to improved outcomes, lower costs July 26, 2024Vol.50 No.30By Matt Ingram
FreeIn the Archives Before the Olympics were smoke-free, tobacco brand deals ran rampant July 26, 2024Vol.50 No.30
Platinum drugs are off the shortage list, but the underlying problem is unsolvedFDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.” July 19, 2024Vol.50 No.29By Jacquelyn Cobb
Free A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital July 19, 2024Vol.50 No.29By Paul Goldberg
U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage dataRankings now include a list of Best Regional Hospitals for Equitable Access July 19, 2024Vol.50 No.29By Matthew Bin Han Ong
Health EquityWhite House Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa July 19, 2024Vol.50 No.29By McKenzie Prillaman
Health Equity Proposed rule by CMS would expand access to cancer treatment at tribal facilities July 19, 2024Vol.50 No.29By Jacquelyn Cobb
Conversation with The Cancer Letter NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”“All research now involves data science at some level.” July 12, 2024Vol.50 No.28By Paul Goldberg
Conversation with The Cancer Letter Infections are a major cause of death in patients treated with CAR T-cell therapyMeta-analysis focused on causes of death, excluding relapse, recurrence July 12, 2024Vol.50 No.28By Matthew Bin Han Ong
Cancer History Project “If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor July 12, 2024Vol.50 No.28By McKenzie Prillaman
